| 1 | Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment. 2021;13:1359 doi: 10.3390/cancers13061359 |
| 2 | Reduced restenosis and enhanced re-endothelialization of functional biodegradable vascular scaffolds by everolimus and magnesium hydroxide. 2022;26: doi: 10.1186/s40824-022-00334-x |
| 3 | Efficacy of Sirolimus Treatment in PEComa–10 Years of Practice Perspective. 2021;10:3705 doi: 10.3390/jcm10163705 |
| 4 | NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets. 2022;23:9985 doi: 10.3390/ijms23179985 |
Cancer Drug Resistance
